US2006239959A1PendingUtilityA1
Method for treating hypercholesterolemia with polyallylamine polymers
Est. expiryJun 18, 2017(expired)· nominal 20-yr term from priority
A61P 3/06A61P 43/00A61P 9/10A61P 3/00A61K 31/785
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for removing bile salts from a patient that includes administering to the patient a therapeutically effective amount of a non-absorbable amine polymers characterized by a repeat unit having the formula: and salts thereof, where n is a positive integer and x is zero or an integer between 1 and about 4.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A method of removing bile salts from a patient comprising administering to said patient a therapeutically effective amount of cross-linked homopolyallylamine,
wherein said cross-linked homopolyallylamine is cross-linked by a multifunctional crosslinking agent, and said multifunctional crosslinking agent is present in an amount from 0.5-25% by weight, based upon the combined weight of allylamine repeat units and multifunctional crosslinking agent.
17 . The method of claim 16 wherein said multifunctional crosslinking agent is present in an amount from about 2.5-20% by weight, based upon the combined weight of allylamine repeat units and multifunctional crosslinking agent.
18 . The method of claim 16 , wherein the patient has a serum LDL level of at least 130 mg/dL.
19 . The method of claim 16 , wherein the multifunctional crosslinking agent comprises epichlorohydrin.
20 . The method of claim 16 , wherein the multifunctional crosslinking Agent is epichlorohydrin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.